Precision

DTIL

DTIL Precision NASDAQ
Add to watchlist
--
At close :
--
  • Post market
  • Summary
    Financials
    News
    Filings
    Profile
    DTIL Chart
    See on advanced chart >

    About

    Precision BioSciences, Inc. is a genome editing company dedicated to improving life through their groundbreaking proprietary genome editing platform, “ARCUS.” They leverage ARCUS in the development of their product candidates, which are designed to treat...
    • Highlight
      A clinical stage gene editing company developing ARCUS®-based ex vivo allogeneic CAR T and in vivo gene editing therapies
    • Industry
    • Exchange
      NASDAQ
    • Listing Date
      03/28/2019
    • Established Date
      Invalid Date
    • Full-time Employees
      109
    • Address
      302 East Pettigrew St. Suite A-100 Durham North Carolina 27701
    • Tel
      1-919-3145512
    • Website
    • Fiscal Year End Date
      12/31
    • Security Type
      Common Stock